Biomolecules & Therapeutics

  • 제28권6호
  • /
  • Pages.542-548
  • /
  • 2020
  • /
  • 1976-9148(pISSN)
  • /
  • 2005-4483(eISSN)
한국응용약물학회 (The Korean Society of Applied Pharmacology)
권호 표지
DOI QR코드

DOI QR Code

Diosmetin and Its Glycoside, Diosmin, Improve Atopic Dermatitis-Like Lesions in 2,4-Dinitrochlorobenzene-Induced Murine Models

  • Park, Sang-a (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Bong, Sim-Kyu (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Lee, Jin Woo (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Park, No-June (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Choi, Yongsoo (Natural Products Research Institute, Korea Institute of Science and Technology) ;
  • Kim, Sang Moo (Department of Marine Food Science and Technology, Gangneung-Wonju National University) ;
  • Yang, Min Hye (College of Pharmacy, Pusan National University) ;
  • Kim, Yong Kee (College of Pharmacy, Sookmyung Women's University) ;
  • Kim, Su-Nam (Natural Products Research Institute, Korea Institute of Science and Technology)
  • 투고 : 2020.07.31
  • 심사 : 2020.08.25
  • 발행 : 2020.11.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Naturally derived diosmetin and its glycoside diosmin are known to be effective in treating inflammatory disease. This study was performed to determine whether diosmin and diosmetin have the effect of improving atopic dermatitis in a 2,4-dinitrochlorobenzen (DNCB)-induced atopic dermatitis (AD) model. DNCB was used to establish AD model in hairless mice. Skin moisture, serum immunoglobulin E (IgE), interleukin 4 (IL-4), and histological analysis were performed to measure the effectiveness of diosmin and diosmetine to improve AD. IL-4 levels were also measured in RBL-2H3 cells. Administration of diosmetin or diosmin orally inhibited the progress of DNCB-induced AD-like lesions in murine models by inhibiting transdermal water loss (TEWL) and increasing skin hydration. Diosmetin or diosmin treatment also reduced IgE and IL-4 levels in AD-induced hairless mouse serum samples. However, in the in vitro assay, only diosmetin, not diosmin, reduced the expression level of IL-4 mRNA in RBL-2H3 cells. Diosmin and diosmetine alleviated the altered epidermal thickness and immune cell infiltration in AD. Diosmin is considered effective in the cure of AD and skin inflammatory diseases by being converted into diosmetin in the body by pharmacokinetic metabolism. Thus, oral administration of diosmetin and diosmin might be a useful agent for the treatment of AD and cutaneous inflammatory diseases.

키워드

참고문헌

  1. Ahmed, S., Mundhe, N., Borgohain, M., Chowdhury, L., Kwatra, M., Bolshette, N., Ahmed, A. and Lahkar, M. (2016) Diosmin modulates the NF-kB signal transduction pathways and downregulation of various oxidative stress markers in alloxan-induced diabetic nephropathy. Inflammation 39, 1783-1797. https://doi.org/10.1007/s10753-016-0413-4
  2. Arab, H. H., Salama, S. A., Omar, H. A., Arafa el, S. A. and Maghrabi, I. A. (2015) Diosmin protects against ethanol-induced gastric injury in rats: novel anti-ulcer actions. PLoS ONE 10, e0122417. https://doi.org/10.1371/journal.pone.0122417
  3. Bao, L., Mohan, G. C., Alexander, J. B., Doo, C., Shen, K., Bao, J. and Chan, L. S. (2017) A molecular mechanism for IL-4 suppression of loricrin transcription in epidermal keratinocytes: implication for atopic dermatitis pathogenesis. Innate Immun. 23, 641-647. https://doi.org/10.1177/1753425917732823
  4. Beck, L. A., Thaci, D., Hamilton, J. D., Graham, N. M., Bieber, T., Rocklin, R., Ming, J. E., Ren, H., Kao, R., Simpson, E., Ardeleanu, M., Weinstein, S. P., Pirozzi, G., Guttman-Yassky, E., Suarez-Farinas, M., Hager, M. D., Stahl, N., Yancopoulos, G. D. and Radin, A. R. (2014) Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N. Engl. J. Med. 371, 130-139. https://doi.org/10.1056/NEJMoa1314768
  5. Bieber, T. (2008) Atopic dermatitis. N. Engl. J. Med. 358, 1483-1494. https://doi.org/10.1056/NEJMra074081
  6. Bogucka-Kocka, A., Woźniak, M., Feldo, M., Kockic, J. and Szewczyk, K. (2013) Diosmin--isolation techniques, determination in plant material and pharmaceutical formulations, and clinical use. Nat. Prod. Commun. 8, 545-550.
  7. Brandt, E. B. and Sivaprasad, U. (2011) Th2 cytokines and atopic dermatitis. J. Clin. Cell. Immunol. 2, 110.
  8. Campanero, M. A., Escolar, M., Perez, G., Garcia-Quetglas, E., Sadaba, B. and Azanza, J. R. (2010) Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: application to a clinical pharmacokinetic study. J. Pharm. Biomed. Anal. 51, 875-881. https://doi.org/10.1016/j.jpba.2009.09.012
  9. Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., Guy, R. H., Macgowan, A. L., Tazi-Ahnini, R. and Ward, S. J. (2009) Epidermal barrier dysfunction in atopic dermatitis. J. Invest. Dermatol. 129, 1892-1908. https://doi.org/10.1038/jid.2009.133
  10. Curro, D. (2018) The role of gut microbiota in the modulation of drug action: a focus on some clinically significant issues. Expert Rev. Clin. Pharmacol. 11, 171-183. https://doi.org/10.1080/17512433.2018.1414598
  11. David Boothe, W., Tarbox, J. A. and Tarbox, M. B. (2017) Atopic dermatitis: pathophysiology. Adv. Exp. Med. Biol. 1027, 21-37. https://doi.org/10.1007/978-3-319-64804-0_3
  12. Diana, G., Catanzaro, M., Ferrara, A. and Ferrari, P. (2000) Activity of purified diosmin in the treatment of hemorrhoids. Clin. Ter. 151, 341-344.
  13. Gandhi, N. A., Pirozzi, G. and Graham, N. M. H. (2017) Commonality of the IL-4/IL-13 pathway in atopic diseases. Expert Rev. Clin. Immunol. 13, 425-437. https://doi.org/10.1080/1744666X.2017.1298443
  14. Guilhou, J. J., Dereure, O., Marzin, L., Ouvry, P., Zuccarelli, F., Debure, C., Van Landuyt, H., Gillet-Terver, M. N., Guillot, B., Levesque, H., Mignot, J., Pillion, G., Fevrier, B. and Dubeaux, D. (1997) Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 48, 77-85. https://doi.org/10.1177/000331979704800113
  15. Hajar, T., Leshem, Y. A., Hanifin, J. M., Nedorost, S. T., Lio, P. A., Paller, A. S., Block, J. and Simpson, E. L.; (the National Eczema Association Task Force) (2015) A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses. J. Am. Acad. Dermatol. 72, 541-549.e2. https://doi.org/10.1016/j.jaad.2014.11.024
  16. Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C. and Leung, D. Y. (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 124, R7-R12. https://doi.org/10.1016/j.jaci.2009.07.012
  17. Kanaze, F. I., Bounartzi, M. I. and Niopas, I. (2004) A validated HPLC determination of the flavone aglycone diosmetin in human plasma. Biomed. Chromatogr. 18, 800-804. https://doi.org/10.1002/bmc.391
  18. Kumar, S., Khandpu, S., Rao, D. N., Wahaab, S. and Khanna, N. (2012) Immunological response to Parthenium hysterophorus in Indian patients with Parthenium sensitive atopic dermatitis. Immunol. Invest. 41, 75-86. https://doi.org/10.3109/08820139.2011.581731
  19. Liu, F. T., Goodarzi, H. and Chen, H. Y. (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin. Rev. Allergy Immunol. 41, 298-310. https://doi.org/10.1007/s12016-011-8252-4
  20. Lloyd, C. M. and Snelgrove, R. J. (2018) Type 2 immunity: expanding our view. Sci. Immunol. 3, eaat1604. https://doi.org/10.1126/sciimmunol.aat1604
  21. Mastuda, H., Morikawa, T., Ueda, K., Managi, H. and Yoshikawa, M. (2002) Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-alpha and IL-4 production from RBL-2H3 cells. Bioorg. Med. Chem. 10, 3123-3128. https://doi.org/10.1016/S0968-0896(02)00227-4
  22. Nogata, Y., Sakamoto, K., Shiratsuchi, H., Ishii, T., Yano, M. and Ohta, H. (2006) Flavonoid composition of fruit tissues of citrus species. Biosci. Biotechnol. Biochem. 70, 178-192. https://doi.org/10.1271/bbb.70.178
  23. Patel, K., Gadewar, M., Tahilyani, V. and Patel, D. K. (2013) A review on pharmacological and analytical aspects of diosmetin: a concise report. Chin. J. Integr. Med. 19, 792-800. https://doi.org/10.1007/s11655-013-1595-3
  24. Perumal, S., Langeshwaran, K., Selvaraj, J., Ponnulakshmi, R., Shyamaladevi, B. and Balasubramanian, M. P. (2018) Effect of diosmin on apoptotic signaling molecules in N-nitrosodiethylamine-induced hepatocellular carcinoma in experimental rats. Mol. Cell. Biochem. 449, 27-37. https://doi.org/10.1007/s11010-018-3339-3
  25. Sawada, E., Yoshida, N., Sugiura, A. and Imokawa, G. (2012) Th1 cytokines accentuate but Th2 cytokines attenuate ceramide production in the stratum corneum of human epidermal equivalents: an implication for the disrupted barrier mechanism in atopic dermatitis. J. Dermatol. Sci. 68, 25-35. https://doi.org/10.1016/j.jdermsci.2012.07.004
  26. Spergel, J. M. and Paller, A. S. (2003) Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol. 112, S118-S127. https://doi.org/10.1016/j.jaci.2003.09.033
  27. Tanaka, T., Makita, H., Kawabata, K., Mori, H., Kakumoto, M., Satoh, K., Hara, A., Sumida, T., Tanaka, T. and Ogawa, H. (1997) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18, 957-965. https://doi.org/10.1093/carcin/18.5.957
  28. Villa, P., Cova, D., De Francesco, L., Guaitani, A., Palladini, G. and Perego, R. (1992) Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. Toxicology 73, 179-189. https://doi.org/10.1016/0300-483X(92)90101-J
  29. Wahlgren, C. F. (1999) Itch and atopic dermatitis: an overview. J. Dermatol. 26, 770-779. https://doi.org/10.1111/j.1346-8138.1999.tb02090.x
  30. Wang, T. Y., Li, Q. and Bi, K. S. (2018) Bioactive flavonoids in medicinal plants: structure, activity and biological fate. Asian J. Pharm. Sci. 13, 12-23. https://doi.org/10.1016/j.ajps.2017.08.004
  31. Yang, M., Tanaka, T., Hirose, Y., Deguchi, T., Mori, H. and Kawada, Y. (1997) Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int. J. Cancer 73, 719-724. https://doi.org/10.1002/(SICI)1097-0215(19971127)73:5<719::AID-IJC18>3.0.CO;2-0